Moderna to Present at Upcoming Conferences in November 2024

Rhea-AI Summary

Moderna (NASDAQ:MRNA) has announced its participation in three major healthcare conferences in November 2024. The company will present at the Guggenheim's Inaugural Healthcare Innovation Conference on November 12th at 10:00am ET, the UBS Global Healthcare Conference on November 13th at 3:30pm PT, and the Jefferies London Healthcare Conference on November 21st at 2:00pm GT. Live webcasts of all presentations will be accessible through the Investors section of Moderna's website, with replays available for at least 30 days after each event.

CAMBRIDGE, MA / ACCESSWIRE / October 31, 2024 / Moderna, Inc. (NASDAQ:MRNA), today announced its participation in the following upcoming investor conferences:

Guggenheim's Inaugural Healthcare Innovation Conference, on Tuesday, November 12^th at 10:00am ET

UBS Global Healthcare Conference, on Wednesday, November 13^th at 3:30pm PT

Jefferies London Healthcare Conference, on Thursday, November 21^st at 2:00pm GT

A live webcast of each of these presentations will be available under "Events and Presentations" in the Investors section of the Moderna website at investors.modernatx.com. A replay of each webcast will be archived on Moderna's website for at least 30 days following the presentation.

About Moderna
Moderna is a leader in the creation of the field of mRNA medicine. Through the advancement of mRNA technology, Moderna is reimagining how medicines are made and transforming how we treat and prevent disease for everyone. By working at the intersection of science, technology and health for more than a decade, the company has developed medicines at unprecedented speed and efficiency, including one of the earliest and most effective COVID-19 vaccines.

Moderna's mRNA platform has enabled the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. With a unique culture and a global team driven by the Moderna values and mindsets to responsibly change the future of human health, Moderna strives to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X (formerly Twitter), Facebook, Instagram, YouTube and LinkedIn.

Investors:
Lavina Talukdar
Senior Vice President & Head of Investor Relations
617-209-5834
Lavina.Talukdar@modernatx.com

SOURCE: Moderna, Inc.

View the original press release on accesswire.com

FAQ

What investor conferences will Moderna (MRNA) attend in November 2024?

Moderna will present at three conferences: Guggenheim's Inaugural Healthcare Innovation Conference (Nov 12), UBS Global Healthcare Conference (Nov 13), and Jefferies London Healthcare Conference (Nov 21).

How can I watch Moderna's (MRNA) November 2024 conference presentations?

Live webcasts will be available under 'Events and Presentations' in the Investors section of Moderna's website at investors.modernatx.com, with replays available for 30 days after each presentation.

When is Moderna (MRNA) presenting at the Guggenheim Healthcare Conference 2024?

Moderna will present at Guggenheim's Inaugural Healthcare Innovation Conference on Tuesday, November 12th at 10:00am ET.

How long will Moderna's (MRNA) November 2024 conference webcasts be available for replay?

The webcasts will be archived on Moderna's website for at least 30 days following each presentation.